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ABSTRACT: A unified strategy for the synthesis of the cis-phlegmarine group of alkaloids is presented, leading to the first synthe-
sis of serratezomine E (1) as well as the putative structure of huperzine N (2).  A contrasteric hydrogenation method was developed 
based on the use of Wilkinson’s catalyst, which allowed the facial selectivity of standard hydrogenation to be completely over-
turned. Calculations were performed to determine the mechanism, and structures for huperzines M and N are reassigned. 
In the field of natural product synthesis there is a growing 
trend towards developing strategies that can prepare diverse 
molecular skeletons from a common intermediate.1 Such ‘uni-
fied synthesis’ approaches have the advantage in that they 
produce the maximum amount of molecular diversity in the 
most efficient manner possible, thereby facilitating structure-
activity relationship studies. Our interest in this field stems 
from our research program to develop a unified synthesis of 
the Lycopodium alkaloids.2 In particular, our efforts have 
focused on the phlegmarine alkaloid subset, since not only do 
their multiple stereochemical arrangements present synthetic 
challenges, but the core framework, embedded throughout the 
Lycopodium alkaloids, would constitute an ideal common 
scaffold in a unified synthesis of these compounds.3,4   
   Previously, we have developed an organocatalyzed tandem 
cyclization to access 5-oxodecahydroquinoline 3 bearing three 
stereogenic centers in a one-pot manner. Subsequent coupling 
generated the first point of diversification, providing vinylpyr-
idines 4 or 5 depending on the conditions employed. Hydro-
genation of the formed alkene led to a second point of diversi-
ty, which from 4 almost exclusively gave the stereochemistry 
required for the synthesis of lycoposerramine Z.5 Similarly, 
hydrogenation of vinylpyridine 5, under the same conditions, 
allowed the synthesis of cermizine B6 (Scheme 1). Access to a 
wide range of C-5 epimeric Lycopodium alkaloids, such as 





































































































Figure 1. Structural conformations and relative stabilities of 6a/b 
and 8a/b, computed at B3LYP/6-311G** (LANL2DZ) level of 
theory  
 
those shown in Scheme 1,7 would require the facial selectivity 
of this hydrogenation step to be completely overturned. 8 We 
herein report a highly efficient process to achieve this objec-
tive and its application to the first total synthesis of ser-
ratezomine E.7a Using this strategy, we also accomplished the 
total synthesis of the putative structure of huperzine N7c and its 
reassignment.  
   The selectivity of the hydrogenation of vinylpyridine 4 (Fig-
ure 1) using either Pd-C or Raney nickel is believed to be 
governed by an axially positioned methyl group, which blocks 
the approach from the lower face of the molecule, leading to 
the kinetic decahydroquinoline 6b (Table 1, entries 1 and 2). A 
priori, compound 7 appeared to be a convenient precursor of 
8a, since its different conformation (Figure 1) could allow a 
kinetic hydrogenation from the bottom face and lead to the 
thermodynamically more stable epimer 8a. However, hydro-
genation of the secondary amine 7 (entry 3) did not give the 
expected reversal of selectivity. An explanation is that the 
haptophilicity9 of the secondary amino function binds it to the 
catalyst surface and thus directs the delivery of the hydrogen 
from the top face of 7 to give 8b as the major epimer. 
  We then evaluated the reductive radical conditions recently 
reported by Shenvi,10 known to give more thermodynamically 
favoured products. Calculations showed that the targeted 6a 
was 2.8 kcal more stable than its epimer 6b (Figure 1), and 
indeed, it was obtained as the main compound in a ratio of 
73:27 (entry 4), although it was difficult to separate from 
significant amounts of byproducts (>30%).11 When the same 
conditions were applied to the N-H compound 7, there was no 
reaction and the starting material was completely recovered 
(entry 5). Similar radical-based methods based on other proto-
cols,12 either directly or modified, were also evaluated, but 
with no significant improvements (entries 6-8). We then as-
sessed homogeneous hydrogenation catalysts and were pleased  
Table 1. Screening of conditions for the reduction reactiona 
 
entry compd methoda yieldb  
(%) 
drc a:b  
 
1 4 H2, Pd-C 100 3:97 
2 4 H2, Ra-Ni 75 14:86 
3 7 H2, Pd-C 100 36:64 
4 4 Mn(dpm)3, PhSiH3,TBHP 63 73:27 
5 7 Mn(dpm)3, PhSiH3,TBHP 0    --- 
6 d 4 Fe2(ox)3.H2O, NaBH4, H2O 10 75:25 
7 e 4 Co(acac)2, Et3SiH, TBHP 7 nd 
8 d 4 Fe(acac)3, PhSiH3 49 67:33 
9 4 H2, [Ir(PCy3)(cod)(py)]PF6 100 68:32 
10 4 H2, [RhCl(PPh3)3] 100 96:4 
a For detailed reactions conditions, see Supporting Information. 
Reactions were performed on a mixture of E:Z isomers (4:1). b 
Yield of hydrogenated compounds refers to the conversion deter-
mined from 1H NMR  spectra. c The ratio was determined by 1H 
NMR spectroscopy of the unpurified reaction mixture. d EtOH 
used as solvent. e PrOH used as solvent and 1,4-cyclohexadiene as 
additive. 
 
to observe that Crabtree’s catalyst provided the same stereose-
lectivity as Mn(dpm)3 but without any byproducts (entry 9). 
Finally, Wilkinson’s catalyst proved more successful, enabling 
us to achieve almost complete diastereoselectivity (96:4) in a 
clean quantitative manner using only 2 mol % of catalyst 
(entry 10).13 
   Given the sterically impeded nature of the β,β disubstituted 
vinyl pyridine and large size of Wilkinson’s catalyst, we pre-
sumed the reaction proceeded via a coordination of the cata-
lyst.14 Indeed, when the analogous benzene analog of 4 (not 
shown) lacking the pyridine nitrogen was prepared, no reduc-
tion was observed.   
   To understand the reaction and account for the excellent 
stereocontrol observed, calculations were performed and the 
proposed reaction mechanism is outlined in Scheme 2. The 
hydrogenated Wilkinson’s catalyst (I) forms an initial com-
plex A by coordination to the double bond and the pyridine 
nitrogen atom of the substrate, releasing two molecules of 
phosphine in the process, which can occur through both faces 
of the double bond. In complex A, the Rh atom is coordinated 
to the pyridine ring and the double bond with short interatomic 
Rh-N (2.4 Å), and Rh-alkene (2.3 Å) distances, inducing a 
slight deconjugation of the double bond and the pyridine ring, 
which is partially responsible for its 10 kcal/mol higher energy  
than the initial hydrogenated Wilkinson catalyst. Thus, the 
initial equilibrium between the starting materials and A is 






























Scheme 2. Proposed Mechanism for the Rh-Catalyzed Hydrogenation of 4 
 
activation energy required for the hydro-rhodation (TS-down 
is only 4 kcal/mol above A) makes the whole process feasible, 
triggering an easy formation of C, and the consumption of the 
starting material. After the insertion of hydrogen into C, the 
reaction proceeds through reductive elimination, liberating the 
final product D. As mentioned, the hydro-rhodation step can 
occur on either face of the double bond, through two diaster-
eoisomeric transition states, TS-down and TS-up (E → G). 
The computed activation energies predict that TS-down is 
favoured by 2.8 kcal/mol over TS-up, justifying the experi-
mental formation of the major diastereoisomer 6a. The main 
difference between the two diasteromeric transition states 
consists of the different orientation of the N-tosyl moiety of 
the substrate. In B, the phenyl ring of the tosyl group forms at 
least three strong π-stacking interactions, with one of the rings 
of the PPh3 group, and with two different H atoms of the bicy-
clic skeleton (see Supporting Information).  During the transi-
tion state, the Rh-alkene bond is even tighter than in A (2.1 
Å), inducing a weakening of the Rh-N coordination (2.5 Å). 
       With the optimum reduction method in hand, transfor-
mation of 4 (prepared in six steps from the commercially 
Scheme 3. Synthesis of serratezomine E (1) 
 
available 5-aminopentanoic acid) led to a concise synthesis of 
serratezomine E (1, Scheme 3). Hydrogenation with Wil-
kinson’s catalyst, and removal of the tosyl group of 6a led to 
the secondary amine 8a in a pure form, and the introduction of 
the required acetyl group gave 9. Subsequent reduction of the 
pyridine provided serratezomine E (1) as a white solid,15 
whose structure was unequivocally confirmed by X-ray analy-
sis (Figure 2), having the absolute configuration (S) at the C2 
piperidine ring and (R) at the C7 decahydroquinoline ring, 
characteristic of phlegmarine alkaloids.16,17  
 
   Figure 2. X-Ray structure of (+)-serratezomine  E (1) 
    An analogous procedure allowed for the synthesis of huper-
zine N (2, Scheme 4). Hydrogenation of 5 with Wilkinson’s 
catalyst gave the desired epimer 10 in a 9:1 ratio. Removal of 
the tosyl group, formation of the N-methyl via reductive ami-
nation with ZnCl218 and reduction of the pyridine gave 11 in 
good overall yield. Finally, oxidation with Na2WO4/ 
urea·H2O25 gave the reported structure of huperzine N, alt-
hough the NMR spectra of 2 did not match those described 
(see SI). Instead, the 13C NMR data of natural huperzine N 
would be explained by structure 14 (Figure 2), whose NMR 
data are consistent with the N-oxide form of the previously 
isolated lycoposerramine Y.19 Indeed, the closely related alka-
loid huperzine M (15)7c should also be reassigned, its NMR 



























































































































Scheme 4. Synthesis of putative huperzine N (2)  
 
 
Figure 3. Revised structure for huperzines M and N  
   In summary, a divergent hydrogenation protocol was devel-
oped, providing access to a range of Lycopodium compounds 
unattainable by standard hydrogenation of common vinyl 
pyridine intermediates. Via rhodium complexation with the 
pyridine nitrogen and selective facial delivery, it was possible 
to invert the course of hydrogenation from 97:3 to 4:96 dr. 
This method was successfully applied for the first total synthe-
sis of serrazomine E as well as huperzine N. The latter turned 
out to be a putative structure, and the natural one was structur-
ally reassigned. The application of this strategy to other cis 
and trans Lycopodium alkaloids is now in progress.  
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